NCT06194045 Nutritional Study to Determine the Effect of Fish Oil on Atopic Dermatitis Status RECRUITING Phase NA
NCT06182436 Virtual Reality for Pain Management During Dupilumab Injection Status RECRUITING Phase NA
NCT06176040 A Study of TAVO101 in Atopic Dermatitis Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06175143 A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis. Status NOT_YET_RECRUITING Phase PHASE1
NCT06174493 Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials Status NOT_YET_RECRUITING Phase N/A
NCT06169527 A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06162507 Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis Status COMPLETED Phase PHASE1/PHASE2
NCT06144424 Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06129136 The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients. Status COMPLETED Phase NA
NCT06119529 A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis Status TERMINATED Phase PHASE1
NCT06116565 A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE2
NCT06108570 Evaluation of the Efficacy of TOPIALYSE Baume Protect+ on Atopic Dermatis Status COMPLETED Phase NA
NCT06101823 Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis Status UNKNOWN Phase PHASE2
NCT06092762 A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06085521 A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06082323 A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers Status RECRUITING Phase PHASE1